1. Patients with chronic renal failure benefit from epoetin alfa (Epogen, Procrit) because the drug: A. replaces erythro
Posted: Tue Mar 15, 2022 3:00 pm
1. Patients with chronic renal failure benefit from epoetin alfa (Epogen, Procrit) because the drug: A. replaces erythropoietin no longer produced in the proximal tubules of the kidney. B. neutralizes the kidney's accumulating waste products that destroy circulating red blood cells. . C. metabolizes the hormone that interferes with RBC production. D. increases the kidney's excretion of substances that interfere with RBC production.